SEC Form 4 · accession 0001193125-26-324445
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Severino
Officer — Chief Executive Officer · Director
Period of report
Jul 28, 2026
Accepted (ET)
Jul 29, 2026 · 8:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 28, 2026 | A | 756,104 | — | A | 756,104 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F2 | $17.74 | Jul 28, 2026 | A | 2,224,342 | A | Jul 28, 2027 | Jul 28, 2036 | Common Stock | 2,224,342 | 2,224,342 | D |
Explanation of responses
- F1The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in substantially equal installments on an annual basis over four years from the date of grant, subject to the Reporting Person's continued employment.
- F2Represents the date upon which the first twenty-five percent of the option granted vests. 1/48th of the total granted option vests and becomes exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continued employment.